Virginia Retirement Systems’s Protagonist Therapeutics PTGX Stock Holding History

Virginia Retirement Systems’s Portfolio PTGX Stock Details PTGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Sell	11,200 -1,800	-14%	-$188K	0.01%	645
2026 Q1	$1.37M	Sell	13,000 -12,400	-49%	-$1.1M	0.01%	505
2025 Q4	$2.22M	Buy	25,400 +9,800	+63%	+$802K	0.01%	400
2025 Q3	$1.04M	Sell	15,600 -3,400	-18%	-$193K	0.01%	588
2025 Q2	$1.05M	Buy	19,000 +1,400	+8%	+$67.2K	0.01%	561
2025 Q1	$851K	Buy	+17,600	New	+$737K	0.01%	598

Other funds holding PTGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Virginia Retirement Systems's PTGX Position: Q2 2026 in Review

Virginia Retirement Systems reduced its Protagonist Therapeutics (PTGX) stake by 14% in Q2 2026, selling an estimated $188K and leaving 11,200 shares worth $1.37M. The position accounts for 0.01% of the portfolio, ranked #645.

Virginia Retirement Systems first reported a position in PTGX in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.22M in Q4 2025. 343 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

Virginia Retirement Systems held 11,200 shares of Protagonist Therapeutics worth $1.37M as of Q2 2026.
Virginia Retirement Systems sold 1,800 Protagonist Therapeutics shares in Q2 2026, an estimated $188K.
Protagonist Therapeutics made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #645 holding.
Virginia Retirement Systems first reported a position in Protagonist Therapeutics in Q1 2025 and has held it in 6 quarters since.
Virginia Retirement Systems's Protagonist Therapeutics position peaked at $2.22M in Q4 2025.
343 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.